Literature DB >> 3742160

Investigation of the maternal to foetal serum concentration gradient of dexamethasone in the rat.

D R Varma.   

Abstract

The basis of the maternal to foetal serum concentration gradient of dexamethasone was investigated in the rat on day 20 of gestation. The pregnant rat was assumed to behave as a two-compartment open model with one maternal and one foetal pool exchanging with each other and each to outside. Bolus injections of unlabelled dexamethasone were made into the mother and of [3H]-dexamethasone into its foetuses and serial maternal and foetal blood samples were collected a number of times. The monitoring of both forms of the drug in each sample permitted the estimation by a non-linear least square approach of two placental and two non-placental clearances. After both maternal and foetal injections of dexamethasone, its concentrations were higher in the maternal than in the foetal serum. Placental clearance of dexamethasone from the foetus to the mother was 824 +/- 40 ml kg-1 h-1 and 8.5 +/- 1 times greater than the placental clearance from the mother to foetus (103 +/- 2 ml kg-1 h-1). Foetal non-placental clearance was zero. It is suggested that a maternal to foetal serum gradient of dexamethasone is caused by its active transfer from the foetal to maternal side.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3742160      PMCID: PMC1917063          DOI: 10.1111/j.1476-5381.1986.tb16254.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

1.  Transplacental passage of dexamethasone in sheep.

Authors:  F Bayard; J P Louvet; Y Ruckebusch; C Boulard
Journal:  J Endocrinol       Date:  1972-08       Impact factor: 4.286

2.  Placental transfer of dexamethasone in near-term sheep.

Authors:  D F Anderson; M K Stock; J H Rankin
Journal:  J Dev Physiol       Date:  1979-12

3.  In vitro metabolism of prednisolone, dexamethasone, betamethasone, and cortisol by the human placenta.

Authors:  A T Blanford; B E Murphy
Journal:  Am J Obstet Gynecol       Date:  1977-02-01       Impact factor: 8.661

4.  Meperidine pharmacokinetics in the maternal-fetal unit.

Authors:  H H Szeto; L I Mann; A Bhakthavathsalan; M Liu; C E Inturrisi
Journal:  J Pharmacol Exp Ther       Date:  1978-08       Impact factor: 4.030

5.  Distribution of dexamethasone between mother and fetus after maternal administration.

Authors:  J D Funkhouser; K J Peevy; P B Mockridge; E R Hughes
Journal:  Pediatr Res       Date:  1978-11       Impact factor: 3.756

6.  Glucocorticoid levels in maternal and cord serum after prenatal betamethasone therapy to prevent respiratory distress syndrome.

Authors:  P L Ballard; P Granberg; R A Ballard
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

7.  Pharmacological studies with lincomycin in late pregnancy.

Authors:  N M Duignan; J Andrews; J D Williams
Journal:  Br Med J       Date:  1973-07-14

8.  Placental transfer of a substituted pteridine from fetus to mother.

Authors:  J L McNay; P G Dayton
Journal:  Science       Date:  1970-02-13       Impact factor: 47.728

9.  Anti-inflammatory and ulcerogenic effects and pharmacokinetics of dexamethasone in protein-deficient rats.

Authors:  D R Varma; S Mulay
Journal:  J Pharmacol Exp Ther       Date:  1980-07       Impact factor: 4.030

10.  A rat model for the study of transplacental pharmacokinetics and its assessment with antipyrine and aminoisobutyric acid.

Authors:  D R Varma; R Ramakrishnan
Journal:  J Pharmacol Methods       Date:  1985-08
View more
  7 in total

1.  Modification of transplacental distribution of salicylate in rats by acidosis and alkalosis.

Authors:  D R Varma
Journal:  Br J Pharmacol       Date:  1988-04       Impact factor: 8.739

2.  Area/moment and compartmental modeling of pharmacokinetics during pregnancy: applications to maternal/fetal exposures to corticosteroids in sheep and rats.

Authors:  Mahesh N Samtani; Matthias Schwab; Peter W Nathanielsz; William J Jusko
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

Review 3.  Drug transfer and metabolism by the human placenta.

Authors:  Michael R Syme; James W Paxton; Jeffrey A Keelan
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 4.  Steroid hormones and brain development: some guidelines for understanding actions of pseudohormones and other toxic agents.

Authors:  B S McEwen
Journal:  Environ Health Perspect       Date:  1987-10       Impact factor: 9.031

5.  Antenatal dexamethasone treatment transiently alters diastolic function in the mouse fetal heart.

Authors:  E J Agnew; A Garcia-Burgos; R V Richardson; H Manos; A J W Thomson; K Sooy; G Just; N Z M Homer; C M Moran; P J Brunton; G A Gray; K E Chapman
Journal:  J Endocrinol       Date:  2019-06-01       Impact factor: 4.286

6.  Counteractive effects of antenatal glucocorticoid treatment on D1 receptor modulation of spatial working memory.

Authors:  Kanwar Virdee; Jiska Kentrop; Bianca Jupp; Bethany Venus; Daniel Hensman; Simon McArthur; James Wilkinson; Trevor W Robbins; Glenda Gillies; Jeffrey W Dalley
Journal:  Psychopharmacology (Berl)       Date:  2016-08-23       Impact factor: 4.530

Review 7.  Glucocorticoids, antenatal corticosteroid therapy and fetal heart maturation.

Authors:  Emma J Agnew; Jessica R Ivy; Sarah J Stock; Karen E Chapman
Journal:  J Mol Endocrinol       Date:  2018-05-02       Impact factor: 5.098

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.